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For over a decade, tissue-type plasminogen activator
(t-PA), a serine protease classically known for its pro-
fibrinolytic role in the vasculature, has been impli-
cated in numerous aspects of the synaptic plasticity
process. But despite being the most intensively stud-
ied protease of the CNS, the mechanisms and molecu-
lar mediators behind the action of t-PA on synaptic ef-
ficacy remain largely undefined. Rather than examine
the role of t-PA in proteolytic remodeling of the synap-
tic extracellularmatrix, this reviewwill focus on the ev-
idence that defines t-PA as a direct modulator of neu-
rotransmission and synaptic plasticity by impacting
on glutamatergic and dopaminergic pathways.
On the basis of spatial and temporal localization, tissue-
type plasminogen activator (t-PA) presents as a candi-
date modulator of neurotransmission. Within the CNS,
the t-PA transcript is regulated in an immediate-early
manner. Both intracellular t-PA protein and mRNA de-
posits have been localized to the synapse. Moreover,
various depolarization agents promote exocytosis of
t-PA from neuronal stores. Once in the extracellular
space, t-PA can convert the proenzyme plasminogen
into its active form, plasmin. Extracellular t-PA activity
is controlled by inhibitors including neuroserpin and
plasminogen activator inhibitor (PAI)-1 and targeted to
cell surfaces by association with Annexin II, LDL recep-
tor-related protein-1 and -1b. Such precise regulation of
t-PA expression and activity, in conjunction with its well-
documented role in long-term potentiation (LTP), mem-
ory formation, and seizure, implicate t-PA as an impor-
tant modulator of neurotransmission.
Participation of t-PA in Glutamatergic Transmission
Glutamate is the main excitatory neurotransmitter of the
mammalian brain. The ionotrophic glutamate receptors
are classified according to their selectivity for the gluta-
mate analogs: NMDA, kainate, and AMPA. The efficacy
of glutamatergic transmission is not fixed, but can vary
in an activity-dependent manner—a phenomenon known
as synaptic plasticity that underlies learning and mem-
ory formation. The NMDA receptor (NMDAR) plays a cen-
tral role in these events. A recent wave of research has
strongly implicated t-PA as a modulator of NMDAR func-
tion, although the mechanism by which t-PA influences
this receptor has been the subject of much debate.
Accordingly, several models explaining the ability of
*Correspondence: robert.medcalf@med.monash.edu.aut-PA to alter NMDAR-mediated processes have been
put forward.
Cleavage of the NR1 Subunit of the NMDA Receptor
The first demonstration of a modulatory role for t-PA in
NMDAR function was provided by Nicole et al., (2001).
In this study, t-PA was shown to enhance NMDA-evoked
rise in free intracellular calcium (D[Ca2+]i) and NMDA-in-
duced cell death in vitro. A physical interaction between
t-PA and the NR1 subunit of the NMDAR was demon-
strated by the coimmunoprecipitation of these agents
from embryonic neuronal membrane proteins. More-
over, these authors showed that incubation of t-PA
with membrane proteins resulted in cleavage of the
NR1 subunit. It was hypothesized that t-PA, via plas-
min-independent proteolysis of NR1 could increase
NMDAR calcium permeability and thereby aggravate
NMDA-induced events (Figure 1). This notion was ad-
vanced by the demonstration that t-PA could cleave a
recombinant NR1 fragment (Fernandez-Monreal et al.,
2004). Mass spectrometry analysis identified Argi-
nine260 as the t-PA-sensitive cleavage site within this
NR1 fragment. It was subsequently shown that mutation
of Arginine260 within this fragment abrogated the ability
of t-PA to cause cleavage (Fernandez-Monreal et al.,
2004).
At the functional level, t-PA was shown to augment the
NMDA-induced D[Ca2+]i in HEK293 cells expressing re-
combinant NMDARs, whereas mutation of Arginine260
abrogated the ability of t-PA to exacerbate NMDA-
evokedD[Ca2+]i. This work formed the first direct link be-
tween t-PA and the NMDAR and argued strongly for a
t-PA-NR1 interaction that impinges on NMDAR currents.
Although there is now substantial evidence to indicate
a relationship between t-PA and the NMDAR (see be-
low), controversy surrounds the mechanistic basis of
this association. In particular, contention surrounds
the capacity of t-PA to cleave the NR1 subunit. Although
one study has corroborated the physical association of
t-PA with the NR1 subunit (Kvajo et al., 2004), three re-
ports have failed to detect cleavage of NR1 by t-PA
(Liu et al., 2004; Matys and Strickland, 2003; Kvajo
et al., 2004). It is hard to reconcile these inconsistencies
in the field. Salient details may rest in the experimental
system used or the developmental stage during which
the experiments were performed. The research which
defined NR1 as a substrate for t-PA utilized material
from embryonic neuronal cultures, whereas the re-
search that failed to detect the t-PA-mediated cleavage
of NR1 utilized lysates prepared from adult mouse brain.
Another possibility may be that the cleavage of NR1 by
t-PA is sensitive to parameters such as ionic strength
(Mars et al., 2005).
That proteolytic activity is a prerequisite for the effect of
t-PA on the NMDAR was concluded from the finding that
t-PA-STOP (a t-PA inhibitor) could attenuate the t-PA en-
hancement of NMDA-induced D[Ca2+]i (Liot et al., 2004).
This dependence on proteolytic activity implies the exis-
tence of a substrate. Notwithstanding the controversy
over NR1 cleavage, the other most likely substrate for
t-PA is plasminogen. At the biochemical level, a role for
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674Figure 1. Mechanisms by which t-PA Influ-
ences Glutamatergic Transmission
Left: t-PA cleavage of the NR1 subunit in-
creases NMDAR ion permeability. In embry-
onic cortical neuronal culture, this cleavage
event augments NMDAR-dependent calcium
flux and excitotoxic cell death. Middle: limbic
system seizure resulting from ethanol with-
drawal (EW) in alcohol-dependent mice.
t-PA potentiates the development of ethanol
dependency and EW-induced seizure via a
nonproteolytic interaction with the NR2B sub-
unit. This potentiation involves increased
NR2B phosphorylation, MAPK-ERK1/2 acti-
vation, and a rise in the number NR2B-
containing NMDARs. Right: LRP-1 is tethered
to the NMDAR via PSD-95. t-PA facilitates
NMDAR-dependent L-LTP at the CA1 syn-
apse by binding to LRP-1 and transducing
a signal that elevates PKA levels. For sim-
plicity, only the exocytosis of t-PA from pre-
synaptic stores is depicted. However, t-PA
stores within the postsynapse have also been
demonstrated (Shin et al., 2004).plasmin in t-PA-mediated NR1 proteolysis was consid-
ered unlikely because the incubation of a recombinant
NR1 fragment or full-length native NR1 with plasmin led
to their complete degradation (Fernandez-Monreal et al.,
2004; Matys and Strickland, 2003). Nonetheless, at the
functional level, a role for plasmin should be fully investi-
gated because plasminogen has already been shown to
enhance NMDA-induced D[Ca2+]i (Inoue et al., 1994).
Even if NR1 is a bona fide t-PA substrate, it remains to
be seen whether this cleavage event can affect the ion
permeability of the NMDAR. As acknowledged by Tray-
nelis and Lipton (2001), direct evidence that NR1 cleav-
age has an electrophysiological consequence is lacking.
Indeed, a study by Centonze et al. (2002) demonstrated
that t-PA2/2 mice displayed unaltered NMDAR-medi-
ated excitatory postsynaptic currents (EPSCs), suggest-
ing that endogenous t-PA does not influence ion flux
through the NMDAR. However, because changes in
free intracellular calcium levels are not a direct reflection
of NMDAR-mediated EPSCs, it is conceivable that the
potentiation of NMDA-induced D[Ca2+]i may lie down-
stream of other receptor-mediated signaling events,
e.g., intracellular store-operated calcium release. As
a result, other routes by which t-PA might influence
NMDA-evoked events cannot be excluded.
Upregulation of the NR2B Subunit by t-PA
A relationship between t-PA and the NMDAR has also
been connoted in the setting of alcoholism. Ethanol di-
rectly interacts with the NMDAR suppressing ion flux
through this channel. Continued suppression of NMDAR
function because of chronic alcohol consumption leads
to a compensatory rise in NMDAR expression and activ-
ity. Such neuroadaptation underlies the development of
ethanol tolerance and dependence. The heightened
NMDAR number and activity as a result of chronic alco-
hol abuse triggers the onset of seizure upon the with-
drawal of ethanol from the diet.
Pawlak et al. (2005) demonstrated that ethanol-
dependent t-PA2/2 mice displayed attenuated seizure
severity relative to their wild-type and plasminogen2/2counterparts upon ethanol withdrawal (EW). In addition,
the administration of t-PA into t-PA2/2 mice augmented
EW-induced seizure severity. Because plasminogen2/2
mice displayed no change in seizure severity, the role
of t-PA in this setting is plasmin independent. Interest-
ingly, intracerebral administration of t-PA-STOP had
no impact on seizure severity in wild-type mice, indicat-
ing that t-PA was acting in a nonproteolytic fashion.
Clues to the underlying mechanism were derived from
the use of the NR2B-specific antagonist, ifenprodil. The
administration of ifenprodil abrogated the enhancing ef-
fect of t-PA on seizure severity. Moreover, the acquisi-
tion of ethanol dependence and EW-induced seizure
was correlated with increased total and phosphorylated
NR2B levels in wild-type, but not t-PA2/2 mice. It was
also shown that t-PA and NR2B could be reciprocally
coimmunoprecipitated. Consistent with a nonproteolytic
mechanism, cleavage of NR2B by t-PA was not ob-
served. Collectively, this data implies that the alteration
of EW-induced seizure by t-PA is not only NR2B-depen-
dent but also mediated by a direct interaction between
NR2B and t-PA (Figure 1).
Based on the knowledge that activation of NR2B-con-
taining NMDARs triggers ERK1/2 phosphorylation, Paw-
lak and colleagues correlated EW-induced seizure with
ERK1/2 activation in wild-type, but not t-PA2/2 mice.
An independent study also reported the ability of t-PA
to trigger ERK1/2 phosphorylation in a manner depen-
dent on NMDAR activation but independent of proteoly-
sis (Medina et al., 2005). Importantly, the ‘‘cause or ef-
fect’’ relationship between phosphorylated ERK1/2
and NR2B upregulation during the acquisition of ethanol
dependence is yet to be delineated. Altogether, the ob-
servation that t-PA physically interacts with NR2B, and
that t-PA-deficiency ablates the NR2B-dependent rise
in phosphorylated ERK1/2 upon seizure induction, rai-
ses the prospect of a t-PA-triggered intracellular signal
that is transduced through the NR2B subunit.
At first glance, the finding that t-PA aggravates EW-
induced seizure is not surprising as t-PA is known to
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675promote kainate-induced seizure spread from the
amygdala to the hippocampus in a plasmin-indepen-
dent manner (Yepes et al., 2002). However, as the natu-
ral t-PA inhibitor, neuroserpin, blunts this seizure prop-
agation, the role of t-PA in kainate-induced seizure
spread depends on proteolysis and is therefore distinct
from its role in EW-induced seizure.
Low-Density Lipoprotein Receptor-Related Protein-1
Lipoprotein receptor-related protein-1 (LRP-1) is a mem-
ber of the low-density lipoprotein receptor (LDLR) family
of endocytic receptors. LRP-1 is widely expressed
throughout the CNS where it mediates the signaling
and catabolism of many ligands. Indeed, LRP-1 endocy-
toses free t-PA and its inhibitory complexes (Makarova
et al. [2003] and references therein). Hence, an alterna-
tive mechanism by which t-PA might impact on
NMDA-mediated events is via its ability to signal through
LRP-1 (Figure 1).
An important study by Huang et al. (1996) demon-
strated that t-PA2/2 mice exhibited impaired late-phase
LTP (L-LTP) along both the Schaffer collateral (CA1) and
Mossy fiber (CA3) neural tracts. Zhuo et al. (2000) ex-
tended these findings by showing that in t-PA2/2 mice,
t-PA application restored LTP along the CA1 pathway.
Intriguingly, coapplication of t-PA with the LDLR pan-
ligand blocker, RAP (receptor-associated protein),
ablated the t-PA-mediated restoration of CA1 LTP. Al-
though other LDLR family members are known to be cru-
cial for CA1 LTP (May et al., 2004), LRP-1 is the most
likely LDLR given its known association with t-PA.
Zhuo and colleagues went on to show that addition of
t-PA increased protein kinase A (PKA) activity in hippo-
campal neurons and that this increase could also be at-
tenuated by RAP. Interestingly, a precedent for t-PA-me-
diated intracellular signal transduction through LRP-1
exists (Wang et al., 2003). Might a LRP-1-mediated rise
in cAMP/PKA levels underlie the ability of t-PA to en-
hance NMDA-induced D[Ca2+]i? At least with regards to
NMDAR ion permeability, this does not appear to be
the case because t-PA application failed to alter NMDAR
excitatory postsynaptic potentials (EPSPs) (Zhuo et al.,
2000). But as changes in electrophysiological properties
and changes in free intracellular calcium are not neces-
sarily coupled events, it remains to be seen whether
a LRP-1-mediated rise in cAMP/PKA underlies the ability
of t-PA to enhance NMDA-induced D[Ca2+]i.
Circumstantial evidence for the participation of LRP-1
during t-PA modulation of NMDAR function can be
inferred from the findings that other LRP-1 ligands—
a-2-macroglobulin, lactoferrin, apo34—also modulate
NMDA-evoked D[Ca2+]i (Qiu et al. [2003] and references
therein). LRP-1 is tethered to the NMDAR via the intra-
cellular scaffold protein, PSD-95. Moreover, this associ-
ation is activity dependent (May et al., 2004). As a result
of this physical association, LRP-1 and its ligands are
ideally situated to be NMDAR modulators.
Conclusion
Several reports have highlighted the NMDAR as the cell-
surface receptor through which t-PA exerts its neuromo-
dulatory effects. Direct cleavage of the NR1 subunit and
a nonproteolytic interaction with the NR2B subunit are
two currently proposed models. In addition, signaling
crosstalk between the NMDAR and LRP-1 may underlie
the ability of t-PA to facilitate NMDA-evoked events.Whether the NMDAR can accommodate all three of
these scenarios remains to be seen. It should be noted,
however, that the experiments that led to these three
postulates were performed on different regions of the
CNS, utilized different experimental systems, and were
performed during different stages of murine develop-
ment. As in the setting of LTP and LTD, the mechanisms
by which t-PA operates may change depending on the
neural compartment and on the developmental stage.
Nonetheless, the number of independent reports dem-
onstrating a relationship between t-PA and the NMDAR
define t-PA as a direct modulator of glutamatergic trans-
mission.
Participation of t-PA in Dopaminergic Transmission
Dopamine is a slow-acting neuromodulatory transmitter
that exerts its effects via two classes of receptors: D1-
like receptors that couple to Gs proteins and elevate
cAMP and D2-like receptors that couple to Gi proteins
and suppress cAMP. Although dopaminergic neurons
are relatively few in number, they exercise diverse and
dramatic control on many neural circuits. Substantial ex-
perimental evidence for t-PA involvement in dopaminer-
gic transmission has been obtained in the synaptic plas-
ticity paradigms of LTP and drug addiction.
Long-Term Potentiation
The striatum is heavily innervated by dopaminergic neu-
rons. Centonze et al. (2002) demonstrated that striatal
spiny neurons from t-PA2/2 mice, despite unaltered
physiological and pharmacological EPSP properties,
harbored a severe impairment in corticostriatal LTP (Fig-
ure 2). In an attempt to mimic D1-receptor activation, it
was shown that pharmacological elevation of cAMP res-
cued corticostriatal LTP in t-PA2/2 mice. Next, it was
shown that the striatal interneurons of t-PA2/2 mice
were refractory to dopamine-mediated depolarization
via D1 receptors. No change in the number of dopami-
nergic afferents could be detected in the t-PA2/2 stria-
tum. It was postulated that t-PA deficiency hinders stria-
tal dopamine D1 signaling; a deficiency that can be
overcome by elevating cAMP levels. In support of the
hypothesis that t-PA facilitates D1-mediated signaling,
a reduced level of D2 receptor was detected in the
t-PA2/2 striatum. As D2 and D1 receptors have oppos-
ing actions on cAMP generation, this reduced D2 recep-
tor level was posited as an adaptation to attenuated
D1-mediated signaling.
In line with LTP being a molecular correlate for learning
and memory formation, cognitive deficits have been
documented in the t-PA2/2 mouse. Indeed, striatal de-
fects in dopaminergic processes has been hypothesized
to be the basis for the reduced capacity of t-PA2/2 mice
to learn an active avoidance task—a behavior that is sen-
sitive to striatal lesion. In this context it was shown that
after a conditioned stimulus, t-PA2/2 mice were worse
than wild-type mice at learning to actively avoid an aver-
sive electrical foot shock (Huang et al., 1996; Calabresi
et al., 2000). It must be noted, however, that aversion-
related memory paradigms are confounded by the fact
that t-PA2/2 mice display reduced anxiety and fear
(Pawlak et al., 2003).
Ties between t-PA and dopaminergic transmission
have also been made in LTP along the CA1 and CA3
pathways. These two forms of hippocampal LTP can
Neuron
676Figure 2. Mechanisms by which t-PA Influ-
ences Dopaminergic Transmission
The D1 class of dopamine receptors couples
to Gs proteins and elevates cAMP/PKA levels
upon activation of adenylate cyclase (AC).
Left: in the striatum, t-PA2/2 mice have im-
paired D1 receptor-mediated signaling that
impedes corticostriatal LTP induction. Right:
in the nucleus accumbens, t-PA-mediated
generation of plasmin triggers dopamine re-
lease upon morphine injection. This plas-
min-induced dopamine release underlies the
plasticity-related behavioral sensitization
brought on by morphine administration.be evoked by the pharmacological elevation of cAMP.
Huang et al. (1996) showed that D1 agonist-induced CA1
LTP was abolished in t-PA2/2 mice. Similarly, forskolin-
induced CA3 L-LTP maintenance was attenuated in
t-PA2/2 mice. Consistent with a proteolytic role for t-PA
in hippocampal LTP, the maintenance of forskolin-
induced CA3 LTP in wild-type mice could be diminished
by exogenous PAI-1 (Baranes et al., 1998). Huang and
colleagues speculated that a dopamine-induced rise in
cAMP might initiate new t-PA gene transcription and
protein synthesis—a step that dramatically facilitates
the long-lasting potentiation of synaptic efficacy in the
hippocampus. This idea is supported by the observation
that dopamine receptor antagonists block methamphet-
amine-induced immediate-early t-PA gene transcription
(Hashimoto et al., 1998) and that forskolin triggers im-
mediate-early t-PA gene transcription in hippocampal
neurons (Baranes et al., 1998).
Based upon the marked deficits in hippocampal LTP
that exist in the t-PA2/2 mouse, it might be expected
that these mice would harbor a severe impairment in
spatial learning and memory (a hippocampus-depen-
dent response). However, no such impairment has
been demonstrated in t-PA2/2 mice (Huang et al.,
1996). Consequently, in the t-PA2/2 mouse, the ob-
served dopaminergic deficiencies in hippocampal LTP
do not strictly translate into defects in spatial learning
and memory. Rather, these defects may impact on other
aspects of memory or even other plasticity-related be-
havioral processes such as anxiety or addiction. Nota-
bly, the fact that t-PA deficiency produces no change
in spatial learning capabilities does not preclude a role
for t-PA in this cognitive process. Indeed, overexpres-
sion of t-PA within the murine CNS enhances both hip-
pocampal LTP and spatial learning and memory perfor-
mance (Madani et al., 1999). Whether an alteration in
dopamine transmission exists within the hippocampus
of these t-PA-overexpressing mice is yet to be as-
sessed.Drug Addiction
Analogous to the setting of LTP and natural memory
formation, drug abuse triggers cellular and behavioral
changes that are experience dependent, long lasting,
and strengthened by repetition. It is widely hypothesized
that the synaptic plasticity process more commonly as-
sociated with memory, also underlies the establishment
of drug addiction. Furthermore, psychomotor stimu-
lants, including cocaine, morphine, and methamphet-
amine are known to rely on dopaminergic transmission.
Given the participation of t-PA in dopaminergic trans-
mission and plasticity-related events, it seems hardly
surprising that recent investigations point to a prominent
role for t-PA in stimulant abuse. Nagai et al. (2004) dem-
onstrated that t-PA can acutely regulate the cellular and
behavioral morphine-induced events in the nucleus ac-
cumbens (NAc) (Figure 2). In this example, contrary to
the aforementioned situation in the striatum, no alter-
ation in dopamine signaling was found. Rather, t-PA2/2
mice exhibited reduced dopamine release in the NAc af-
ter morphine injection. This deficit in dopamine release
was reversed in t-PA2/2 mice by microinjection of t-PA
or plasmin into the NAc prior to morphine administration.
At the behavioral level, t-PA2/2 mice displayed attenu-
ated morphine-induced hyperlocomotion. Accordingly,
microinjection of t-PA or plasmin into the t-PA2/2 NAc
increased morphine-induced hyperlocomotion. t-PA2/2
and plasminogen2/2 mice were then shown to be par-
tially resistant to the rewarding effects of morphine as
assessed by conditioned place preference (a NAc-
dependent task). Altogether, the work of Nagai and col-
leagues demonstrates that t-PA, via the generation of
plasmin within the NAc, participates in both the cellular
(dopamine release) and behavioral (hyperlocomotion)
responses to morphine administration.
Conclusion
Defects in D1 signaling within the striatum have been
correlated with t-PA deficiency, whereas in the NAc,
defects in dopamine release have been discovered in
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677t-PA2/2mice. In the setting of morphine abuse, t-PA ap-
pears to function in a plasmin-dependent manner, al-
though the plasmin-sensitive target remains unknown.
With regards to hippocampal LTP, it is clear that t-PA re-
quires proteolytic activity to promote LTP along both
CA1 and CA3 circuits. Curiously, with CA1 LTP, the facil-
itatory influence of t-PA has been ascribed to LRP-
1-mediated signaling (Zhuo et al., 2000), to dopamine-
triggered t-PA gene transcription (Huang et al., 1996),
and to plasmin-mediated generation of neurotrophins
(Pang et al., 2004). How these critical events can coexist
at the same synapse is a question yet to be addressed.
Furthermore, whether t-PA-mediated plasmin genera-
tion is central to LTP and LTD along other neural tracks
remains to be determined. Indeed, roles for t-PA in hip-
pocampal-dependent learning that are reliant upon pro-
teolytic capacity but independent of plasminogen are
likely to exist because the acquisition of passive avoid-
ance was diminished by the intrahippocampal infusion
of t-PA-STOP into wild-type mice, whereas infusion of
urokinase (that also activates plasminogen) could not
substitute for t-PA in the acquisition of passive avoid-
ance in t-PA2/2 mice (Pawlak et al., 2002).
Although no mechanistic commonality has been as-
signed to the t-PA-mediated plasticity paradigms of
LTP and drug addiction, shifts in dopaminergic trans-
mission are a recurrent theme. As with the t-PA modula-
tion of NMDA-induced events, the participation of t-PA
in dopaminergic transmission, LTP, and memory forma-
tion awaits further delineation.
Concluding Remarks
Extravascular roles for the plasminogen activator/plas-
min system have recently arisen. The generation of the
t-PA2/2 mouse has focused attention on the participa-
tion of t-PA in CNS function and dysfunction. Although
not addressed in this review, numerous studies have de-
fined t-PA as a deleterious contributor to excitotoxicity
and other neurodegenerative paradigms; the effect of
t-PA on zinc-induced toxicity is a notable exception
(Strickland [2001] and references therein). In more phys-
iological settings, the neurological activities of t-PA are
contextual with synaptic plasticity processes.
As a protease that undergoes stimulus-dependent
exocytosis from neuronal stores, t-PA also participates
in the proteolytic remodeling of cell-cell and cell-matrix
molecules that arises during synaptic plasticity. This
role for t-PA is exemplified within the visual cortex dur-
ing monocular deprivation-induced plasticity (Berardi
et al., 2004). In addition to this role for t-PA in shaping
the synaptic extracellular scaffold, a growing number
of observations are demonstrating that t-PA can also
impact on neurotransmission in a more direct and re-
ceptor-mediated fashion. To this end, the research dem-
onstrating the participation of t-PA in the plasticity-
related paradigms of seizure, LTP, and drug addiction
has been highlighted in this review.
An alteration of ion channel properties (NR1 cleav-
age), an increase in cell-surface receptor activity and
number (NR2B activation), intracellular signaling cas-
cades (MAPK or PKA), and shifts in modulatory trans-
mission (changes in dopaminergic properties) are all
ways in which t-PA might alter synaptic efficacy. Several
neurological outcomes have been attributed to the t-PA-mediated generation of plasmin; however, the pertinent
plasmin substrates remain largely unknown. Similarly,
a number of proteolytic yet plasmin-independent roles
for t-PA have also been described, implicating the exis-
tence of other currently unidentified non-plasminogen
substrates for t-PA within the CNS.
Despite the fact that the molecular mediators and
mechanisms behind the neurobiology of t-PA remain
elusive, the vast array of experimental evidence clearly
denotes t-PA as a multifaceted modulator of neurotrans-
mission and the plasticity process. This action of t-PA is
clearly distinct from its classical role in haemostasis and
fibrinolysis.
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